Boston Trust Walden Corp Bristol Myers Squibb CO Transaction History

Boston Trust Walden Corp

$13.3 Billion
Q2 2024

A detailed history of Boston Trust Walden Corp transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Boston Trust Walden Corp holds 14,211 shares of BMY stock, worth $755,883. This represents 0.0% of its overall portfolio holdings.

Number of Shares

14,211

Previous 14,311 0.7%

Holding current value

$755,883

Previous $776,000 23.97%

% of portfolio

0.0%

Previous 0.01%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 19, 2024	SELL	$40.25 - $52.99 $4,025 - $5,299	-100 Reduced 0.7%	14,211 $590,000
Q1 2024 Apr 22, 2024	SELL	$47.98 - $54.4 $29,027 - $32,912	-605 Reduced 4.06%	14,311 $776,000
Q4 2023 Jan 24, 2024	SELL	$48.48 - $57.85 $16,580 - $19,784	-342 Reduced 2.24%	14,916 $765,000
Q3 2023 Oct 18, 2023	BUY	$57.89 - $64.73 $44,633 - $49,906	771 Added 5.32%	15,258 $885,000
Q2 2023 Jul 24, 2023	BUY	$63.71 - $70.74 $48,037 - $53,337	754 Added 5.49%	14,487 $926,000
Q1 2023 Apr 19, 2023	SELL	$65.71 - $74.53 $85,685 - $97,187	-1,304 Reduced 8.67%	13,733 $951,000
Q4 2022 Jan 20, 2023	SELL	$68.48 - $81.09 $20,544 - $24,327	-300 Reduced 1.96%	15,037 $0
Q3 2022 Oct 19, 2022	BUY	$0.13 - $76.84 $180 - $106,884	1,391 Added 9.97%	15,337 $1.09 Million
Q2 2022 Jul 22, 2022	BUY	$72.62 - $79.98 $6,826 - $7,518	94 Added 0.68%	13,946 $1.07 Million
Q1 2022 Apr 20, 2022	SELL	$61.48 - $73.72 $202,884 - $243,276	-3,300 Reduced 19.24%	13,852 $1.01 Million
Q4 2021 Jan 21, 2022	SELL	$53.63 - $62.52 $58,993 - $68,772	-1,100 Reduced 6.03%	17,152 $1.07 Million
Q3 2021 Oct 25, 2021	BUY	$59.17 - $69.31 $39,466 - $46,229	667 Added 3.79%	18,252 $1.08 Million
Q2 2021 Jul 22, 2021	SELL	$61.91 - $67.42 $18,573 - $20,226	-300 Reduced 1.68%	17,585 $1.18 Million
Q4 2020 Jan 15, 2021	BUY	$57.74 - $65.43 $6,640 - $7,524	115 Added 0.65%	17,885 $1.11 Million
Q3 2020 Oct 14, 2020	SELL	$57.43 - $63.64 $8,557 - $9,482	-149 Reduced 0.83%	17,770 $1.07 Million
Q2 2020 Jul 23, 2020	SELL	$54.82 - $64.09 $54,820 - $64,090	-1,000 Reduced 5.29%	17,919 $1.05 Million
Q1 2020 Apr 21, 2020	SELL	$46.4 - $67.43 $178,176 - $258,931	-3,840 Reduced 16.87%	18,919 $1.06 Million
Q4 2019 Jan 10, 2020	BUY	$49.21 - $64.19 $296,342 - $386,552	6,022 Added 35.98%	22,759 $1.46 Million
Q1 2019 Apr 16, 2019	SELL	$45.12 - $53.8 $12,227 - $14,579	-271 Reduced 1.59%	16,737 $799,000
Q4 2018 Jan 17, 2019	SELL	$48.76 - $63.23 $50,271 - $65,190	-1,031 Reduced 5.72%	17,008 $884,000
Q3 2018 Oct 23, 2018	SELL	$55.19 - $62.25 $9,327 - $10,520	-169 Reduced 0.93%	18,039 $1.12 Million
Q2 2018 Jul 25, 2018	SELL	$50.53 - $62.98 $58,210 - $72,552	-1,152 Reduced 5.95%	18,208 $1.01 Million
Q1 2018 Apr 13, 2018	SELL	$59.92 - $68.98 $2,336 - $2,690	-39 Reduced 0.2%	19,360 $1.23 Million
Q4 2017 Jan 29, 2018	SELL	$59.94 - $65.35 $55,564 - $60,579	-927 Reduced 4.56%	19,399 $1.19 Million
Q3 2017 Oct 13, 2017	BUY	$55.23 - $63.74 $1.12 Million - $1.3 Million	20,326	20,326 $1.3 Million

Others Institutions Holding BMY

# of Institutions

2,428

Shares Held

1.5B

Call Options Held

29.7M

Put Options Held

32.2M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Boston Trust Walden Corp, based on Form 13F filings with the SEC.

News

Stay updated on Boston Trust Walden Corp with notifications on news.

Account

Boston Trust Walden Corp Bristol Myers Squibb CO Transaction History